ANIX- Anixa Biosciences, Inc.
Anixa Biosciences, Inc. (ANIX) has 5 insiders with recent SEC Form 4 filings, including 10 buys and 0 sells. ANIX is classified in the Biotechnology industry within the Health Care sector.
Insider Ownership
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Dir | 987.0K | $3.65M | +14.8K | |
| CEO | 640.8K | $2.37M | +10.0K | |
| CFO | 175.0K | $647.5K | - | |
| Dir | 135.0K | $499.5K | - | |
| Dir | 25.0K | $92.5K | - |
Activity
Buys and sells only
Transactions
10 filings · page 8
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jan 14, 2020 | Kumar Amit62 | Chief Executive Officer | Buy | 20,000 | $2.99 | $59,800.00 | +11.5% | |
| Jan 14, 2020 | Titterton Lewis H Jr65 | Director | Buy | 7,400 | $3.22 | $23,828.00 | +0.8% | |
| Sep 13, 2019 | Titterton Lewis H Jr65 | Director | Buy | 15,000 | $4.10 | $61,500.00 | +1.7% | |
| Sep 13, 2019 | Kumar Amit62 | Chief Executive Officer | Buy | 10,000 | $4.12 | $41,200.00 | +6.1% | |
| Apr 29, 2019 | Cavalier David | Director | Buy | 2,000 | $4.21 | $8,420.00 | New | |
| Apr 29, 2019 | Monahan John J | Director | Buy | 900 | $4.22 | $3,798.00 | +1.8% | |
| Apr 26, 2019 | Kumar Amit62 | Chief Executive Officer | Buy | 4,000 | $4.21 | $16,840.00 | +2.5% | |
| Apr 26, 2019 | Baskies Arnold M48 | Director | Buy | 10,000 | $4.28 | $42,800.00 | +1,000% | |
| Apr 24, 2019 | Kumar Amit62 | Chief Executive Officer | Buy | 10,000 | $4.27 | $42,700.00 | +6.7% | |
| Apr 22, 2019 | Titterton Lewis H Jr65 | Director | Buy | 50,000 | $4.09 | $204,500.00 | +5.9% |